Page 100 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 3 The Pathology of Neoplasia 79

150. Smedley RC, Spangler WL, Esplin DG, et al.: Prognostic mark- 175. Moore AS, Madewell BR, Lund JK: Immunohistochemical evalu-
ers for canine melanocytic neoplasms: a comparative review of the ation of intermediate filament expression in canine and feline neo-
literature and goals for future investigation, Vet Pathol 48:54–72, plasms, Am J Vet Res 50:88–92, 1989.
VetBooks.ir 151. Esplin DG: Survival of dogs following surgical excision of histo- 176. Desnoyers MM, Haines DM, Searcy GP: Immunohistochemical
2011.
detection of intermediate filament proteins in formalin fixed nor-
logically well-differentiated melanocytic neoplasms of the mucous
mal and neoplastic canine tissues, Can J Vet Res 54:360–365, 1990.
membranes of the lips and oral cavity, Vet Pathol 45:889–896, 177. Frost D, Lasota J, Miettinen M: Gastrointestinal stromal tumors
2008. and leiomyomas in the dog: a histopathologic, immunohistochemi-
152. Goldschmidt M, Pena L, Rasotto R, et al.: Classification and grad- cal, and molecular genetic study of 50 cases, Vet Pathol 40:42–54,
ing of canine mammary tumors, Vet Pathol 48:117–131, 2011. 2003.
153. Karayannopoulou M, Kaldrymidou E, Constantinidis TC, et al.: 178. Russell KN, Mehler SJ, Skorupski KA, et al.: Clinical and immu-
Histological grading and prognosis in dogs with mammary carci- nohistochemical differentiation of gastrointestinal stromal tumors
nomas: application of a human grading method, J Comp Pathol from leiomyosarcomas in dogs: 42 cases (1990-2003), J Am Vet
133:246–252, 2005. Med Assoc 230:1329–1333, 2007.
154. Goldschmidt MH, Pena L, Zappulli V: Tumors of the mammary 179. Dailey DD, Ehrhart EJ, Duval DL, et al.: DOG1 is a sensitive and
gland. In Meuten DJ, editor: Tumors in domestic animals, ed 5th, specific immunohistochemical marker for diagnosis of canine gas-
Ames, Iowa, 2017, John Wiley & Sons, Inc, pp 733–757. trointestinal stromal tumors, J Vet Diagn Invest 27:268–277, 2015.
155. Pena L, De Andres PJ, Clemente M, et al.: Prognostic value of his- 180. von Beust BR, Suter MM, Summers BA: Factor VIII-related anti-
tological grading in noninflammatory canine mammary carcinomas gen in canine endothelial neoplasms: an immunohistochemical
in a prospective study with two-year follow-up: relationship with study, Vet Pathol 25:251–255, 1988.
clinical and histological characteristics, Vet Pathol 50:94–105, 2013. 181. Giuffrida MA, Bacon NJ, Kamstock DA: Use of routine histo-
156. Vail DM, Powers BE, Getzy DM, et al.: Evaluation of prognostic pathology and factor VIII-related antigen/von Willebrand factor
factors for dogs with synovial sarcoma: 36 cases (1986-1991), J Am immunohistochemistry to differentiate primary hemangiosarcoma
Vet Med Assoc 205:1300–1307, 1994. of bone from telangiectatic osteosarcoma in 54 dogs, Vet Comp
157. Craig LE, Julian ME, Ferracone JD: The diagnosis and prognosis of Oncol 15:1232–1239, 2017.
synovial tumors in dogs: 35 cases, Vet Pathol 39:66–73, 2002. 182. Wilting J, Papoutsi M, Christ B, et al.: The transcription factor
158. Craig LE, Krimer PM, Cooley AJ: Canine synovial myxoma: 39 Prox1 is a marker for lymphatic endothelial cells in normal and
cases, Vet Pathol 47:931–936, 2010. diseased human tissues, FASEB J 16:1271–1273, 2002.
159. Klahn SL, Kitchell BE, Dervisis NG: Evaluation and comparison 183. Galeotti F, Barzagli F, Vercelli A, et al.: Feline lymphangiosar-
of outcomes in dogs with periarticular and nonperiarticular histio- coma—definitive identification using a lymphatic vascular marker,
cytic sarcoma, J Am Vet Med Assoc 239:90–96, 2011. Vet Dermatol 15:13–18, 2004.
160. Lu JE, Dubielzig R: Canine eyelid granular cell tumor: a report of 184. Halsey CH, Worley DR, Curran K, et al.: The use of novel lym-
eight cases, Vet Ophthalmol 15:406–410, 2012. phatic endothelial cell-specific immunohistochemical markers to
161. Liu CH, Liu CI, Liang SL, et al.: Intracranial granular cell tumor in differentiate cutaneous angiosarcomas in dogs, Vet Comp Oncol
a dog, J Vet Med Sci 66:77–79, 2004. 14:236–244, 2016.
162. Kamstock DA, Fredrickson R, Ehrhart EJ: Lipid-rich carcinoma of 185. Fulmer AK, Mauldin GE: Canine histiocytic neoplasia: an over-
the mammary gland in a cat, Vet Pathol 42:360–362, 2005. view, Can Vet J 48:1041–1043, 2007.
163. Kwon HJ, Park MS, Kim DY, et al.: Round cell variant of myxoid 186. Moore PF: A review of histiocytic diseases of dogs and cats, Vet
liposarcoma in a Japanese Macaque (Macaca fuscata), Vet Pathol Pathol 51:167–184, 2014.
44:229–232, 2007. 187. Pierezan F, Mansell J, Ambrus A, et al.: Immunohistochemical
164. Avakian A, Alroy J, Rozanski E, et al.: Lipid-rich pleural mesothe- expression of ionized calcium binding adapter molecule 1 in cuta-
lioma in a dog, J Vet Diagn Invest 20:665–667, 2008. neous histiocytic proliferative, neoplastic and inflammatory disor-
165. Avallone G, Pellegrino V, Muscatello LV, et al.: Spindle cell lipoma ders of dogs and cats, J Comp Pathol 151:347–351, 2014.
in dogs, Vet Pathol 54:792–794, 2017. 188. Willmann M, Mullauer L, Guija de Arespacochaga A, et al.: Pax5
166. Rannou B, Helie P, Bedard C: Rectal plasmacytoma with intracel- immunostaining in paraffin-embedded sections of canine non-
lular hemosiderin in a dog, Vet Pathol 46:1181–1184, 2009. Hodgkin lymphoma: a novel canine pan pre-B- and B-cell marker,
167. Rasheed S: Characterization of a differentiated cat melanoma cell Vet Immunol Immunopathol 128:359–365, 2009.
line, Cancer Res 43:3379–3384, 1983. 189. Ferrer L, Fondevila D, Rabanal R, et al.: Immunohistochemical
168. Kuwata K, Shibutani M, Kemmochi Y, et al.: A neuroendocrine detection of CD3 antigen (pan T marker) in canine lymphomas,
carcinoma of undetermined origin in a dog, J Toxicol Pathol J Vet Diagn Invest 5:616–620, 1993.
23:151–155, 2010. 190. Milner RJ, Pearson J, Nesbit JW, et al.: Immunophenotypic classi-
169. Rizzo SA, Newman SJ, Hecht S, et al.: Malignant mediastinal fication of canine malignant lymphoma on formalin-mixed paraffin
extra-adrenal paraganglioma with spinal cord invasion in a dog, wax-embedded tissue by means of CD3 and CD79a cell markers,
J Vet Diagn Invest 20:372–375, 2008. Onderstepoort J Vet Res 63:309–313, 1996.
170. Rowland PH, Valentine BA, Stebbins KE, et al.: Cutaneous plas- 191. Caniatti M, Roccabianca P, Scanziani E, et al.: Canine lymphoma:
macytomas with amyloid in six dogs, Vet Pathol 28:125–130, immunocytochemical analysis of fine-needle aspiration biopsy, Vet
1991. Pathol 33:204–212, 1996.
171. Kuwamura M, Kanehara T, Yamate J, et al.: Amyloid-producing 192. Felisberto R, Matos J, Alves M, et al.: Evaluation of Pax5 expres-
odontogenic tumor in a Shih-Tzu dog, J Vet Med Sci 62:655–657, sion and comparison with BLA.36 and CD79alphacy in feline
2000. non-Hodgkin lymphoma, Vet Comp Oncol 15:1257–1268, 2017.
172. Hirayama K, Endoh C, Kagawa Y, et al.: Amyloid-producing 193. Walls AF, Jones DB, Williams JH, et al.: Immunohistochemi-
odontogenic tumors of the facial skin in three cats, Vet Pathol cal identification of mast cells in formaldehyde-fixed tissue using
54:218–221, 2017. monoclonal antibodies specific for tryptase, J Pathol 162:119–126,
173. Yamate J, Murai F, Izawa T, et al.: A rhabdomyosarcoma arising in 1990.
the larynx of a dog, J Toxicol Pathol 24:179–182, 2011. 194. Smedley RC, Lamoureux J, Sledge DG, et al.: Immunohistochemi-
174. Dabbs DJ: Diagnostic immunohistochemistry theranostic and genomic cal diagnosis of canine oral amelanotic melanocytic neoplasms, Vet
applications, ed 3, Philadelphia, 2010, Saunders. Pathol 48:32–40, 2011.